Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Müller

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Spine|May 17, 2023
Duration of Surgery and Intraoperative Blood Pressure Management Are Modifiable Risk Factors for Postoperative Neurocognitive Disorders After Spine Surgery: Results of the Prospective CONFESS StudyJonas Müller, Stephan Nowak, Martin Weidemeier, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 21, 2019
A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytesIbrahim El-Battrawy, Sebastian Albers, Lukas Cyganek, et al.
Frontiers in Cell and Developmental Biology|November 19, 2019
Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesIbrahim El-Battrawy, Jonas Müller, Zhihan Zhao, et al.
The Lancet. Microbe|May 11, 2022
Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort studyAnke Thielebein, Yemisi Ighodalo, Abubakar Taju, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2022
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, NigeriaMirjam Groger, Peter Akhideno, Christine J Kleist, et al.
Nature Microbiology|June 12, 2026
Host-virus determinants of Ebola virus persistence in a human cerebral organoid modelLina Widerspick, Santiago Vidal Freire, Johanna F Steffen, et al.
Journal of Virology|August 21, 2020
Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed TissuesJulia R Port, David M Wozniak, Lisa Oestereich, et al.
International Journal of Molecular Sciences|August 12, 2022
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem CellsRujia Zhong, Theresa Schimanski, Feng Zhang, et al.
Open Forum Infectious Diseases|October 25, 2024
Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern NigeriaEphraim Ogbaini-Emovon, George Akpede, Sylvanus Okogbenin, et al.
The Journal of Infectious Diseases|November 25, 2025
Presence of Lassa Virus RNA in Cerebrospinal Fluid Indicating Neuroinvasive Lassa Fever in Pediatric Patients From Edo State, NigeriaHannah Caroline Sophie Müller, Cyril Oshomah Erameh, Joseph Okoeguale, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Spine|May 17, 2023
Duration of Surgery and Intraoperative Blood Pressure Management Are Modifiable Risk Factors for Postoperative Neurocognitive Disorders After Spine Surgery: Results of the Prospective CONFESS StudyJonas Müller, Stephan Nowak, Martin Weidemeier, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 21, 2019
A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytesIbrahim El-Battrawy, Sebastian Albers, Lukas Cyganek, et al.
Frontiers in Cell and Developmental Biology|November 19, 2019
Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesIbrahim El-Battrawy, Jonas Müller, Zhihan Zhao, et al.
The Lancet. Microbe|May 11, 2022
Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort studyAnke Thielebein, Yemisi Ighodalo, Abubakar Taju, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2022
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, NigeriaMirjam Groger, Peter Akhideno, Christine J Kleist, et al.
Nature Microbiology|June 12, 2026
Host-virus determinants of Ebola virus persistence in a human cerebral organoid modelLina Widerspick, Santiago Vidal Freire, Johanna F Steffen, et al.
Journal of Virology|August 21, 2020
Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed TissuesJulia R Port, David M Wozniak, Lisa Oestereich, et al.
International Journal of Molecular Sciences|August 12, 2022
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem CellsRujia Zhong, Theresa Schimanski, Feng Zhang, et al.
Open Forum Infectious Diseases|October 25, 2024
Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern NigeriaEphraim Ogbaini-Emovon, George Akpede, Sylvanus Okogbenin, et al.
The Journal of Infectious Diseases|November 25, 2025
Presence of Lassa Virus RNA in Cerebrospinal Fluid Indicating Neuroinvasive Lassa Fever in Pediatric Patients From Edo State, NigeriaHannah Caroline Sophie Müller, Cyril Oshomah Erameh, Joseph Okoeguale, et al.
Pageof 7